A MAGE-1-encoded HLA-A24-binding synthetic peptide induces specific anti-tumor cytotoxic T lymphocytes

International Journal of Cancer

Volumn 80, Issue 2, 1999, Pages 169-172

  Fujie, Tatsuo ^a   Tahara, Kouichirou ^a   Tanaka, Fumiaki ^a   Mori, Masaki ^a   Takesako, Kazutou ^b   Akiyoshi, Tsuyoshi ^a,c  

^a KYUSHU UNIVERSITY   (Japan)

^b TAKARA SHUZO CO LTD   (Japan)

^c KYUSHU CENTRAL HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

SYNTHETIC PEPTIDE;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER IMMUNOTHERAPY; CYTOTOXIC T LYMPHOCYTE; HLA SYSTEM; HUMAN; HUMAN CELL; LYMPHOBLASTOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ALLELES; ANTIBODIES, MONOCLONAL; ANTIBODY SPECIFICITY; ANTIGENS, NEOPLASM; CELL LINE; GENETIC CODE; HLA-A ANTIGENS; HUMANS; NEOPLASM PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; T-LYMPHOCYTES, CYTOTOXIC; T-LYMPHOCYTES, REGULATORY; TUMOR CELLS, CULTURED;

EID: 0033579910     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19990118)80:2<169::AID-IJC1>3.0.CO;2-P     Document Type: Article

References (21)

1. BRASSEUR, F. and 28 OTHERS, Expression of MAGE genes in primary and metastatic cutaneous melanoma. Int. J. Cancer, 63, 375-380 (1995).
2. CELIS, E., FIKES, J., WENTWORTH, P., SIDNEY, J., SOUTHWOOD, S., MAEWAL, A., DEL GUERCIO, M.-F., SETTE, A. and LIVINGSTON, B., Identification of potential CTL epitopes of tumor-associated antigen MAGE-1 for five common HLA-A alleles. Mol. Immunol., 31, 1423-1430 (1994a).
3. CELIS, E., TSAI, V., CRIMI, C., DEMARS, R., WENTWORTH, P.A., CHESNUT, R.W., GREY, H.M., SETTE, A. and SERRA, H.M., Induction of anti-tumor cytotoxic T lymphocytes in normal humans using primary cultures and synthetic peptide epitopes. Proc. nat. Acad. Sci. (Wash.), 91, 2105-2109 (1994b).
4. CHOMCZYNSKI, P. and SACCHI, N., Single-step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Anal. Biochem., 162, 156-159 (1987).
5. DONG, R.P., KIMURA, A., OKUBO, R., SHINAGAWA, H., TAMAI, H., NISHIMURA, Y. and SASAZUKI, T., HLA-A and DPB1 loci confer susceptibility to Graves' disease. Hum. Immunol., 35, 165-172 (1992).
6. FUJIE, T., TANAKA, F., MORI, M., TAKESAKO, K., SUGIMACHI, K. and AKIYOSHI, T., Induction of anti-tumor cytotoxic T lymphocytes from the peripheral blood mononuclear cells of cancer patients using HLA-A2 restricted MAGE-3 peptide in vitro. Clin. Cancer Res., 3, 2425-2430 (1997).
7. HERMAN, J., VAN DER BRUGGEN, P., LUESCHERT, I.F., MANDRUZZATO, S., ROMERO, P., THONNARD, J., FLEISCHHAUER, K., BOON, T. and COULIE, P.G., A peptide encoded by human gene MAGE-3 and presented by HLA-B44 induces cytolytic T lymphocytes that recognize tumor cells expressing MAGE-3. Immunogenetics, 43, 377-383 (1996).
8. IMANISHI, T., AKAZA, T. KIMURA, A., TOKUNAGA, K. and GOJOBORI, T., Allele and haplotype frequencies for HLA and complement loci in various ethnic groups. In K. Tsuji, M. Aizawa and T. Sasazuki (eds.), HLA 1991: proceedings of the eleventh International histocompatibility workshop and conference, Vol. 1, pp. 1065-1068, Oxford University Press, Oxford (1992).
9. INOUE, H., MORI, M., LI, J., MIMORI, K., HONDA, M., NAKASHIMA, H., MAFUNE, K., TANAKA, Y. and AKIYOSHI, T., Human esophageal carcinomas frequently express the tumor-rejection antigens of MAGE genes. Int. J. Cancer, 63, 523-526 (1995).
10. LI, J., YANG, Y., FUJIE, T., BABA, K., UEO, H., MORI, M. and AKIYOSHI, T., Expression of BAGE, GAGE and MAGE genes in human gastric carcinoma. Clin. Cancer Res., 2, 1619-1625 (1996).
11. MARCHAND, M. and 20 OTHERS, Tumor regression responses in melanoma patients treated with a peptide encoded by gene MAGE-3. Int. J. Cancer, 63, 883-885 (1995).
12. SALGALLER, M.L., WEBER, J.S., KOENIG, S., YANNELLI, J.R. and ROSENBERG, S.A., Generation of specific anti-melanoma reactivity by stimulation of human tumor-infiltrating lymphocytes with MAGE-1 synthetic peptide. Cancer Immunol. Immunother., 39, 105-116 (1994).
13. TANAKA, F., FUJIE, T., GO, H., BABA, K., MORI, M., TAKESAKO, K. and AKIYOSHI, T., Efficient induction of anti-tumor cytotoxic T lymphocytes from a healthy donor using HLA-A2-restricted MAGE-3 peptide in vitro. Cancer Immunol. Immunother., 44, 21-26 (1997a).
14. TANAKA, F., FUJIE, T., TAHARA, K., MORI, M., TAKESAKO, K., SETTE, A., CELIS, E. and AKIYOSHI, T., Induction of antitumor cytotoxic T lymphocytes with a MAGE-3-encoded synthetic peptide presented by human leukocyte antigen-A24. Cancer Res., 57, 4465-4468 (1997b).
15. TOKUNAGA, K., NAKAMURA, Y., SAKATA, K., FUJIMORI, K., OHKUBO, M., SAWADA, K. and SAKIYAMA, S., Enhanced expression of a glyceraldehyde-3-phosphate dehydrogenase gene in human lung cancers. Cancer Res., 47, 5616-5619 (1987).
16. TRAVERSARI, C., VAN DER BRUGGEN, P., LUESCHER, I.F., LURQUIN, C., CHOMEZ, P., VAN PEL, A., DE PLAEN, E., AMAR-COSTESEC, A. and BOON, T., A nonapeptide encoded by human gene MAGE-1 is recognized on HLA-A1 by cytolytic T lymphocytes directed against tumor antigen MZ2-E. J. exp. Med., 176, 1453-1457 (1992).
17. VALMORI, D., LIÉNARD, D., WAANDERS, G., RIMOLDI, D., CEROTTINI, J.-C. and ROMERO, P., Analysis of MAGE-3-specific cytolytic T lymphocytes in human leukocyte antigen-A2 melanoma patients. Cancer Res., 57, 735-741 (1997).
18. VAN DER BRUGGEN, P., BASTIN, J., GAJEWSKI, T., COULIE, P.G., BOEL, P., DE SMET, C., TRAVERSARI, C., TOWNSEND, A. and BOON, T., A peptide encoded by human gene MAGE-3 and presented by HLA-A2 induces cytolytic T lymphocytes that recognize tumor cells expressing MAGE-3. Europ. J. Immunol., 24, 3038-3043 (1994a).
19. VAN DER BRUGGEN, P., SZIKORA, J.-P., BOEL, P., WILDMANN, C., SOMVILLE, M., SENSI, M. and BOON, T., Autologous cytolytic T lymphocytes recognize a MAGE-1 nonapeptide on melanomas expressing HLA-Cw1601. Europ. J. Immunol., 24, 2134-2140 (1994b).
20. VAN DER BRUGGEN, P., TRAVERSARI, C., CHOMEZ, P., LURQUIN, C., DE PLAEN, E., VAN DEN EYNDE, B., KNUTH, A. and BOON, T., A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma. Science, 254, 1643-1647 (1991).
21. VAN PEL, A., VAN DER BRUGGEN, P., COULIE, P.G., BRICHARD, V.G., LETHÉ, B., VAN DEN EYNDE, B., UYTTENHOVE, C., RENAUD, J.C. and BOON, T., Genes coding for tumor antigens recognized by cytolytic T lymphocytes. Immunol. Rev., 145, 229-250 (1995).